TABLE 3.
All Patients (n = 72) | Survivors (n = 56) | Nonsurvivors (n = 16) | P† | |
---|---|---|---|---|
Glucose, mg/dL‡ | ||||
n (% of total) | 72 (100) | 56 (100) | 16 (100) | |
Median (IQR) | 343 (324–401) | 340 (323–385) | 386 (328–473) | 0.14 |
pH | ||||
n (% of total) | 49 (68) | 34 (61) | 15 (94) | |
Median (IQR) | 7.30 (7.16–7.39) | 7.33 (7.25–7.39) | 7.17 (6.84–7.36) | 0.009 |
tCO2, mmol/L | ||||
n (% of total) | 64 (89) | 50 (89) | 14 (88) | |
Median (IQR) | 18.5 (15–21) | 19 (15.8–21.0) | 16.5 (7.5–21.8) | 0.494 |
PCO2, mm Hg | ||||
n (% of total) | 48 (67) | 34 (61) | 14 (88) | |
Median (IQR) | 42.5 (35.0–57.9) | 41.5 (34.8–54.5) | 56.0 (34.8–102.8) | 0.225 |
WBC (×103/µL) | ||||
n (% of total) | 66 (92) | 50 (89) | 16 (100) | |
Median (IQR) | 12.6 (9.9–18.4) | 12.5 (9.9–19.7) | 13.0 (9.9–17.2) | 0.675 |
Hematocrit, % | ||||
n (% of total) | 66 (92) | 50 (89) | 16 (100) | |
Median (IQR) | 35.2 (30.8–39.5) | 35.1 (31.9–39.2) | 35.7 (28.4–42.3) | 0.928 |
Platelets, ×103/µL | ||||
n (% of total) | 64 (89) | 48 (86) | 16 (100) | |
Median (IQR) | 277 (195–385) | 285 (217–418) | 159 (105–301) | 0.010 |
BUN,‡ mg/dL | ||||
n (% of total) | 62 (86) | 48 (86) | 14 (88) | |
Median (IQR) | 12 (9–19) | 11 (8–18) | 13 (11–21) | 0.307 |
Creatinine,‡ mg/dL | ||||
n (% of total) | 36 (50) | 27 (48) | 9 (56) | |
Median (IQR) | 0.7 (0.5–1.0) | 0.7 (0.5–1.0) | 0.6 (0.6–0.9) | 0.927 |
Urinalysis | ||||
n (% of total) | 38 (53) | 30 (54) | 8 (50) | |
Ketones ≥2+ | 13% | 13% | 13% | 0.721 |
Glucose ≥2+ | 42% | 47% | 25% | 0.426 |
Values calculated from those patients who had laboratory values measured; not every patient had all laboratory tests.
Comparison of survivors versus nonsurvivors.
To convert glucose from mg/dL to mmol/L, multiply by 0.0555; to convert creatinine to µmol/L, multiply by 88.3; to convert BUN to mmol/L, multiply by 0.357.
tCO2 indicates total serum CO2 concentration; WBC, white blood cell count; PCO2, partial pressure of carbon dioxide; BUN, blood urea nitrogen.